 |
Development of oxaliplatin in the treatment
of colorectal cancer
Potential role for oxaliplatin in overcoming 5-FU
resistance
Key recent and ongoing clinical trials with oxaliplatin
Comparison of capecitabine/oxaliplatin (XELOX)
versus FOLFOX
Improved survival due to newer chemotherapy agents
Nonprotocol management of younger patients presenting
with metastatic colorectal cancer
Substituting capecitabine for infusional 5-FU
|
| |
Select publications
regarding oxaliplatin in metastatic colorectal cancer |
| |
|
XELOX versus FOLFOX in a young patient with metastatic
disease
Reduction in neutropenia with capecitabine/oxaliplatin
Hand-foot syndrome with capecitabine alone and in
combination with oxaliplatin
Phase III trial of XELOX versus FOLFOX in the metastatic
setting
Capecitabine/oxaliplatin in the adjuvant setting
Substituting capecitabine for 5-FU |
| |
Select publications regarding
capecitabine in metastatic colorectal cancer |
| |
Faculty disclosures |
